Sinocare Inc.

Shenzhen Stock Exchange:300298.SZ

Sector

🏥 Health Care

Industries

💻 Telehealth

🔬 Clinical Trials

🏬 Consumer Packaged Goods

🏥 Hospitals & Clinics

🩺 Medical Instruments

Location

China

Market Cap

USD 1.68 B

Share Price

USD 2.96

Avg Daily Volume

5,582,916

Change (1 day)

1.10%

Change (1 year)

-16.76%

Change (YTD)

-16.27%

Sinocare Inc. EBITDA Margin for the year ending December 31, 2024: 15.12%

Sinocare Inc. EBITDA Margin is 15.12% for the year ending December 31, 2024, a 14.26% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Sinocare Inc. EBITDA Margin for the year ending December 31, 2023 was 13.23%, a -53.43% change year over year.
Sinocare Inc. EBITDA Margin for the year ending December 31, 2022 was 28.42%, a 86.68% change year over year.
Sinocare Inc. EBITDA Margin for the year ending December 31, 2021 was 15.22%, a -10.44% change year over year.
Sinocare Inc. EBITDA Margin for the year ending December 31, 2020 was 17.00%, a -32.35% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	EBITDA Margin	Net Income Margin	EBT Margin	Operating Income Margin

Shenzhen Stock Exchange: 300298.SZ

Sinocare Inc.

CEO	Mr. Shao Bo Li
IPO Date	March 19, 2012
Location	China
Headquarters	No. 265 Guyuan Road
Employees	4,809
Sector	🏥 Health Care
Industries Telehealth 🔬 Clinical Trials 🏬 Consumer Packaged Goods 🏥 Hospitals & Clinics 🩺 Medical Instruments

Description

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.